V001-2313 Screening compound: N-{4-[4-(2-fluorophenyl)piperazin-1-yl]-3-{[2-(morpholin-4-yl)ethyl]sulfamoyl}phenyl}-3-phenylpropanamide

V001-2313 Screening compound: N-{4-[4-(2-fluorophenyl)piperazin-1-yl]-3-{[2-(morpholin-4-yl)ethyl]sulfamoyl}phenyl}-3-phenylpropanamide
V001-2313 Screening compound: N-{4-[4-(2-fluorophenyl)piperazin-1-yl]-3-{[2-(morpholin-4-yl)ethyl]sulfamoyl}phenyl}-3-phenylpropanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V001-2313
N-{4-[4-(2-fluorophenyl)piperazin-1-yl]-3-{[2-(morpholin-4-yl)ethyl]sulfamoyl}phenyl}-3-phenylpropanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V001-2313

Molecular Formula

C31H38FN5O4S (C31 H38 FN5 O4 S)

Compound Name

N-{4-[4-(2-fluorophenyl)piperazin-1-yl]-3-{[2-(morpholin-4-yl)ethyl]sulfamoyl}phenyl}-3-phenylpropanamide

IUPAC name

N-{4-[4-(2-fluorophenyl)piperazin-1-yl]-3-{[2-(morpholin-4-yl)ethyl]sulfamoyl}phenyl}-3-phenylpropanamide

SMILES

O=C(CCc1ccccc1)Nc(cc1)cc(S(NCCN2CCOCC2)(=O)=O)c1N(CC1)CCN1c(cccc1)c1F

InChI

InChI=1S/C31H38FN5O4S/c32-27-8-4-5-9-28(27)36-16-18-37(19-17-36)29-12-11-26(34-31(38)13-10-25-6-2-1-3-7-25)24-30(29)42(39,40)33-14-15-35-20-22-41-23-21-35/h1-9,11-12,24,33H,10,13-23H2,(H,34,38)

InChI Key

MXOIQLDZHMBAMW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19980435

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

595.74

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

4.459

Distribution Coefficient, logD

4.450

Water Solubility, LogSw

-4.29

Polar Surface Area

82.718

Acid Dissociation Constant (pKa)

10.08

Base Dissociation Constant (pKb)

5.67

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

38.70

V001-2313 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Nucleic Acid Ligands (8311 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V001-2313 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V001-2313?
Check Price and Availability of V001-2313, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V001-2313 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V001-2313
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V001-2313
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V001-2313 available by request